A new play titled “Kramer/Fauci” explores the complex relationship between playwright and AIDS activist Larry Kramer and Dr.
CenterPoint (CNP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bilibili (BILI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.